Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy
Summary: Advances in the development of therapeutic extracellular vesicles (EVs) for cancer immunotherapy have allowed them to emerge as an alternative to cell therapy. In this proof-of-concept work, we develop bispecific EVs (BsEVs) by genetically engineering EV-producing dendritic cells (DCs) with...
| Published in: | Cell Reports |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723011506 |
